Mammograms are unlikely to benefit older women with increased comorbidity, as they would probably die from something else before they could develop breast cancer. That is what results from a new study on more than [more]
Seminal data from decades ago already demonstrated a marked underrepresentation of older patients in clinical trials: now an analysis of more than 300 randomised clinical trials (RCTs) shows not only that the disparity persists but the gap between trial and population median ages is widening. [more]
When it comes to breast cancer screening with mammography, are women receiving a coherent message about the best age to start and to stop, and about frequency? A survey examined the situation in the United [more]
Not so long ago, research protocols excluded older cancer patients based on chronologic age. Now they exclude patients with comorbidities, and as most older patients suffer additional ailments, they do not fit the protocols. But [more]
Karol Sikora, a medical oncologist who has directed cancer services at a major London hospital, triggered an angry reaction earlier this year when he suggested that younger patients should have priority when it comes to [more]